Literature DB >> 26895837

Type I IFN Does Not Promote Susceptibility to Foodborne Listeria monocytogenes.

Michelle G Pitts1, Tanya Myers-Morales1, Sarah E F D'Orazio2.   

Abstract

Type I IFN (IFN-α/β) is thought to enhance growth of the foodborne intracellular pathogen Listeria monocytogenes by promoting mechanisms that dampen innate immunity to infection. However, the type I IFN response has been studied primarily using methods that bypass the stomach and, therefore, fail to replicate the natural course of L. monocytogenes infection. In this study, we compared i.v. and foodborne transmission of L. monocytogenes in mice lacking the common type I IFN receptor (IFNAR1(-/-)). Contrary to what was observed using i.v. infection, IFNAR1(-/-) and wild-type mice had similar bacterial burdens in the liver and spleen following foodborne infection. Splenocytes from wild-type mice infected i.v. produced significantly more IFN-β than did those infected by the foodborne route. Consequently, the immunosuppressive effects of type I IFN signaling, which included T cell death, increased IL-10 secretion, and repression of neutrophil recruitment to the spleen, were all observed following i.v. but not foodborne transmission of L. monocytogenes. Type I IFN was also previously shown to cause a loss of responsiveness to IFN-γ through downregulation of the IFN-γ receptor α-chain on macrophages and dendritic cells. However, we detected a decrease in surface expression of IFN-γ receptor α-chain even in the absence of IFN-α/β signaling, suggesting that in vivo, this infection-induced phenotype is not type I IFN-dependent. These results highlight the importance of using the natural route of infection for studies of host-pathogen interactions and suggest that the detrimental effects of IFN-α/β signaling on the innate immune response to L. monocytogenes may be an artifact of the i.v. infection model.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895837      PMCID: PMC4799772          DOI: 10.4049/jimmunol.1502192

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

2.  Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.

Authors:  Katja Fink; Karl S Lang; Nataly Manjarrez-Orduno; Tobias Junt; Beatrice M Senn; Martin Holdener; Shizuo Akira; Rolf M Zinkernagel; Hans Hengartner
Journal:  Eur J Immunol       Date:  2006-08       Impact factor: 5.532

3.  Hyperinduction of host beta interferon by a Listeria monocytogenes strain naturally overexpressing the multidrug efflux pump MdrT.

Authors:  Kierstyn T Schwartz; Joshua D Carleton; Sarah J Quillin; Stuart D Rollins; Daniel A Portnoy; Jess H Leber
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

4.  Listeria-infected myeloid dendritic cells produce IFN-beta, priming T cell activation.

Authors:  Hanping Feng; Dong Zhang; Deborah Palliser; Pengcheng Zhu; Shenghe Cai; Ann Schlesinger; Laura Maliszewski; Judy Lieberman
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

5.  Identification of an IFN-gamma-producing neutrophil early in the response to Listeria monocytogenes.

Authors:  Jiyi Yin; Thomas A Ferguson
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

6.  The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen.

Authors:  Taiki Aoshi; Javier A Carrero; Vjollca Konjufca; Yukio Koide; Emil R Unanue; Mark J Miller
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

7.  Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription.

Authors:  Staci J Kearney; Christine Delgado; Emily M Eshleman; Krista K Hill; Brian P O'Connor; Laurel L Lenz
Journal:  J Immunol       Date:  2013-08-09       Impact factor: 5.422

8.  The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response.

Authors:  Kislay Parvatiyar; Zhiqiang Zhang; Rosane M Teles; Songying Ouyang; Yan Jiang; Shankar S Iyer; Shivam A Zaver; Mirjam Schenk; Shang Zeng; Wenwan Zhong; Zhi-Jie Liu; Robert L Modlin; Yong-jun Liu; Genhong Cheng
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

9.  Directed evolution and targeted mutagenesis to murinize Listeria monocytogenes internalin A for enhanced infectivity in the murine oral infection model.

Authors:  Ian R Monk; Pat G Casey; Colin Hill; Cormac G M Gahan
Journal:  BMC Microbiol       Date:  2010-12-13       Impact factor: 3.605

10.  Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Authors:  Victoria Auerbuch; Dirk G Brockstedt; Nicole Meyer-Morse; Mary O'Riordan; Daniel A Portnoy
Journal:  J Exp Med       Date:  2004-08-09       Impact factor: 14.307

View more
  20 in total

1.  Enrichment of Neutrophils and Monocytes From the Liver Following Either Oral or Intravenous Listeria monocytogenes Infection.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  Curr Protoc Immunol       Date:  2020-09

2.  Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill Opsonized Listeria monocytogenes.

Authors:  Michelle G Pitts; Travis A Combs; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Secretion of c-di-AMP by Listeria monocytogenes Leads to a STING-Dependent Antibacterial Response during Enterocolitis.

Authors:  Alexander Louie; Varaang Bhandula; Daniel A Portnoy
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

Review 4.  Impact of Type I Interferons on Susceptibility to Bacterial Pathogens.

Authors:  Adeline Peignier; Dane Parker
Journal:  Trends Microbiol       Date:  2021-02-02       Impact factor: 18.230

Review 5.  Type I Interferons in Bacterial Infections: A Balancing Act.

Authors:  Pavel Kovarik; Virginia Castiglia; Masa Ivin; Florian Ebner
Journal:  Front Immunol       Date:  2016-12-26       Impact factor: 7.561

6.  Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection.

Authors:  Emily M Eshleman; Christine Delgado; Staci J Kearney; Rachel S Friedman; Laurel L Lenz
Journal:  PLoS Pathog       Date:  2017-05-22       Impact factor: 6.823

Review 7.  Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial Infections.

Authors:  Deann T Snyder; Jodi F Hedges; Mark A Jutila
Journal:  J Immunol Res       Date:  2017-04-26       Impact factor: 4.818

Review 8.  Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology.

Authors:  Johanna Pott; Silvia Stockinger
Journal:  Front Immunol       Date:  2017-03-14       Impact factor: 7.561

Review 9.  A Comparison of Oral and Intravenous Mouse Models of Listeriosis.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  Pathogens       Date:  2018-01-20

10.  Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis.

Authors:  Kailyn L Stefan; Avner Fink; Neeraj K Surana; Dennis L Kasper; Suryasarathi Dasgupta
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.